Sponsor Pipeline

Nerviano Medical Sciences (Shanghai) Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07374419
Atamparib in Patients With Advanced Solid Tumors		 Recruitment opened
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07374419 Atamparib in Patients With Advanced Solid Tumors NSCLC Adenocarcinoma Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Nerviano Medical Sciences (Shanghai) Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free